Clear.bio raises €1.7M Growth round
29 September 2025· Amsterdam, The Netherlands· health, digital_therapeutics, ai, b2b, software_hardware
The company will use the funding to accelerate the nationwide rollout of its digital diabetes program in the Netherlands and obtain permanent reimbursement for its digital therapy in France and Germany, as well as empower more individuals to take charge of their health and expand its proven solution internationally.
Investors
LeadHorizon Flevoland
Also participating
Future Food FundDutch Trade & Investment Fund of Invest International
About Clear.bio
Key People
Piet Hein van DamFounder & CEO
Madelon BrackeFounder & CSO
Jim LesemanChief Operating Officer
Parul VatsChief Technology Officer
Stage
Growth
Headquarters
Amsterdam, The Netherlands
Founded
2019
Team Size
21–50
Sectors
healthdigital_therapeuticsaib2bsoftware_hardware
Source: https://siliconcanals.com/news/startups/healthtech/clear-bio-bags-e1-7m-funding/